Latest Form 4 insider transactions

Sidney B Deboer, a Director of Lithia Motors Inc, reported a transaction in 81 shares of common stock on August 3, 2026.

Frank Lamberti, Chief Commercial Officer of Herbalife Ltd., reported a transaction in 1,710 shares of common stock on August 4, 2026.

Kevin G Lokay, a Director of Galera Therapeutics, Inc., reported a transaction in 240 shares of common stock on August 3, 2026.

Albert L Lord, a Director of AppTech Payments Corp., purchased 40,000 shares of common stock on July 31, 2026.

Nancy T Chang, a Director and 10% owner of Galera Therapeutics, Inc., reported multiple transactions in common stock on May 15, 2026.

Even Yoav Har, a Director of Innoviz Technologies Ltd., received 90,162 shares of common stock on August 4, 2026.

Olin Corporation is reminding shareholders that their vote is crucial for the proposed merger with Huntsman Corporation, with the special meeting of shareholders approaching.

Olin Corporation is reminding shareholders that their vote is crucial for the proposed merger with Huntsman Corporation, with the special meeting of shareholders approaching.

Ray N Walker Jr, a Director of Mplx Lp, received 2,696 shares of common stock on April 30, 2026.

Lawrence M Alleva, a Director of Galera Therapeutics, Inc., reported multiple transactions in common stock on August 3, 2026.

John P Surma, a Director of Mplx Lp, received 3,029 shares of common stock on April 30, 2026.

William L. Williams Iii, a Director of Live Oak Bancshares, Inc., sold 8,400 shares of common stock on August 3, 2026 for $43.08 per share.

Courtney Spencer, Chief Experience Officer of Live Oak Bancshares, Inc., sold 154 shares of common stock on August 4, 2026 for $43.68 per share.

Dimitrios Dosis, Chief Commercial Pmts Officer of Mastercard Inc, received 2,303 shares of common stock on August 3, 2026.

David G Lucht, a Director of Live Oak Bancshares, Inc., sold 2,000 shares of common stock on August 4, 2026 for $44.36 per share.

Ara Mahdessian, Chief Executive Officer and a Director of ServiceTitan, Inc., sold 88,053 shares of common stock on August 3, 2026.

Thomas B Sabol, Chief Financial Officer of Amtech Systems Inc, received 15,000 shares of common stock on August 4, 2026.

J Michael Stice, a Director of Mplx Lp, received 3,029 shares of common stock on April 30, 2026.

Kristen N Sieffert, President of Finance of America Companies Inc., sold 750 shares of common stock on August 3, 2026 for $23.61 per share.

Joel F. Sussman, Chief Accounting Officer of Galera Therapeutics, Inc., reported a transaction in 10,000 shares of common stock on August 3, 2026.

Adam L. Stanley, a Director of Gatx Corp, received 28 shares of common stock on August 3, 2026.

Guy Shechter, President & COO of Amtech Systems Inc, received 25,000 shares of common stock on August 4, 2026.

Eldar Mordechay Cegla, Chief Financial Officer of Innoviz Technologies Ltd., reported multiple transactions in common stock on August 4, 2026.

Robert C Daigle, Chairman & CEO and a Director of Amtech Systems Inc, received 50,000 shares of common stock on August 4, 2026.

Michael R. Friedman, a Director of Galera Therapeutics, Inc., reported multiple transactions in common stock on May 15, 2026.

Frank M Semple, a Director of Mplx Lp, received 3,029 shares of common stock on April 30, 2026.

Barry Ticho, CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc., sold 7,176 shares of common stock on August 3, 2026.

Frederick R Wilson, a Director of Coinbase Global, Inc., sold 35,068 shares of common stock on August 3, 2026.

Michael F Mahoney, Chairman, President & CEO and a Director of Boston Scientific Corp, purchased 186,240 shares of common stock on August 3, 2026 for $48.33 per share.

Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., purchased 693,332 shares of common stock on August 3, 2026.